David Fajgenbaum, MD, MBA, on Repurposing Cancer Drugs to Treat COVID-19

March 08, 2021 By The ASCO Post Staff

David Fajgenbaum, MD, MBA, of the University of Pennsylvania, talks about his research efforts to find an already-approved drug that could treat his orphan disease—multicentric Castleman disease—and how that methodology may be applied to the coronavirus and the cytokine storm it can cause (Symposium 5).

Related Content